A phase II study of sequential carboplatin (C), paclitaxel (P) and topetecan (T) in patients with previously untreated advanced ovarian cancer

被引：0
|
作者：
Agarwal, R
Seckl, MJ
Nelstrop, A
Rustin, GJS
机构：
[1] Charing Cross Hosp, Dept Med Oncol, London W6 8RF, England
[2] Mt Vernon Hosp, Northwood HA6 2RN, Middx, England
来源：
BRITISH JOURNAL OF CANCER | 1999年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P315
引用
收藏
页码：107 / 107
页数：1
相关论文
共 50 条
  • [31] Randomised phase II study of ASA404 combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancer
    McKeage, M. J.
    Von Pawel, J.
    Reck, M.
    Jameson, M. B.
    Rosenthal, M. A.
    Sullivan, R.
    Gibbs, D.
    Mainwaring, P. N.
    Serke, M.
    Lafitte, J-J
    Chouaid, C.
    Freitag, L.
    Quoix, E.
    BRITISH JOURNAL OF CANCER, 2008, 99 (12) : 2006 - 2012
  • [32] A phase I-II study with carboplatin (C) and weekly paclitaxel (P) in advanced NSCLC
    Fabi, A
    Barduagni, M
    De Marco, S
    De Marinis, F
    Cortesi, E
    Foggi, CM
    Chiapparino, E
    Gareri, R
    Venturoli, AL
    Cognetti, F
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S263 - S264
  • [33] Paclitaxel and carboplatin in pretreated advanced gastric cancer: A phase II study
    Stathopoulos, GP
    Rigatos, SK
    Fountzilas, G
    Polyzos, A
    Stathopoulos, JG
    ONCOLOGY REPORTS, 2002, 9 (01) : 89 - 92
  • [34] Phase II study of paclitaxel and carboplatin in advanced gastric cancer previously treated with 5-fluorouracil and platinum
    Chang, HM
    Kim, TW
    Ryu, BY
    Choi, SJ
    Park, YH
    Lee, JS
    Kim, WK
    Kang, YK
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2005, 35 (05) : 251 - 255
  • [35] Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer
    Neijt, JP
    Engelholm, SA
    Tuxen, MK
    Sorensen, PG
    Hansen, M
    Sessa, C
    de Swart, CAM
    Hirsch, FR
    Lund, B
    van Houwelingen, HC
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (17) : 3084 - 3092
  • [36] Paclitaxel/carboplatin, followed by Topotecan in advanced ovarian cancer, a phase I study
    Sadozye, A
    Chan, S
    Carmichael, J
    BRITISH JOURNAL OF CANCER, 1999, 80 : 106 - 106
  • [37] Phase I feasibility trial of carboplatin, paclitaxel, and gemcitabine in patients with previously untreated epithelial ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study
    Look, KY
    Bookman, MA
    Schol, J
    Herzog, TJ
    Rocereto, T
    Vinters, J
    GYNECOLOGIC ONCOLOGY, 2004, 92 (01) : 93 - 100
  • [38] Tallimustine in advanced previously untreated colorectal cancer, a phase II study
    Punt, CJA
    Humblet, Y
    Roca, E
    Dirix, LY
    Wainstein, R
    Polli, A
    Corradino, I
    BRITISH JOURNAL OF CANCER, 1996, 73 (06) : 803 - 804
  • [39] Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer
    Johnson, DH
    Fehrenbacher, L
    Novotny, WF
    Herbst, RS
    Nemunaitis, JJ
    Jablons, DM
    Langer, CJ
    DeVore, RF
    Gaudreault, J
    Damico, LA
    Holmgren, E
    Kabbinavar, F
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) : 2184 - 2191
  • [40] Phase I study of alternating doublets of topotecan/carboplatin and paclitaxel/carboplatin in patients with newly diagnosed, advanced ovarian cancer
    Gordon, AN
    Hancock, KC
    Matthews, CM
    Messing, M
    Stringer, CA
    Doherty, MG
    Teneriello, M
    GYNECOLOGIC ONCOLOGY, 2002, 85 (01) : 129 - 135
12345